Announced Thu, 2 Apr · 11:40 IST
Trading Window Closure for Q4 FY26 Financial Results
Compliance View source PDF
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+9.6%1-day move
₹5.54
prior close
₹5.63
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.5+2.5+2.5+2.5+9.6+15.0+20.6+26.5+32.9+37.2+24.4+26.2+17.9+4.7
Up moveDown movePending
AI summary
Vivimed Labs has informed exchanges that the trading window for dealing in shares will remain closed from 01.04.2026 until 48 hours after the declaration of financial results for Q4 and FY ended March 31, 2026. This is pursuant to SEBI's insider trading regulations. The board meeting date to approve the results will be announced later. During this period, insiders and designated persons cannot trade in company shares.
Likely market impact
Routine compliance; insiders restricted from trading until results are announced. Watch for upcoming Q4 FY26 results.